Fifteen institutions issued a statement to that effect on Sunday in a bid to counter prevailing scepticism about the existence and treatability of the disease, which affects a growing number of Swiss.
Alzheimer Switzerland and the Memory Center of Geneva University Hospital (HUG) are among the organisations that took this position, in line with the 2014-2019 national strategy on dementia.
Dementia, according to these institutions, is clearly a disease that is not part of the normal ageing process. The causes are mainly neurodegenerative or vascular.
Patients, they say, have the right to receive the best treatment.
“This stance, which is based on long consideration, was necessary for the enormous responsibility that we have towards our patients,” Giovanni Frisoni, director of the HUG Memory Center, told Swiss news agency Keystone-SDA.
Search for therapies
It is also a question of responding to “deniers” for whom Alzheimer’s is not a disease.
“This minority makes a lot of noise but does not contribute in any way to the reflection on the disease and the search for therapies,” Frisoni says.
In France, he notes, the costs of dementia drugs have not been reimbursed by health insurance since last year. The products Aricept, Ebixa, Exelon and Reminyl are the only ones approved and reimbursed in Switzerland.
“Without them there is no alternative,” Frisoni stresses.
Demographic changes
Although these drugs do not treat Alzheimer’s, they have nevertheless proved their effectiveness. They temporarily improve the condition of patients or stabilise cognitive symptoms for up to 18 months, according to the joint statement.
Early diagnosis and treatment also improve people’s autonomy, allowing them to live longer at home. The combination of pharmacological and non-pharmacological therapeutic approaches is necessary and is emphasised in the position paper.
Currently 151,000 people have dementia in Switzerland. Due to demographic changes, the medical community estimates 300,000 people will be affected by dementia in 2040.
More
More
A special kind of home for people with dementia
This content was published on
Around 150,000 people have dementia in Switzerland, with the figure set to double in the next 20 years. What’s the best way to care for these people?
Swiss football boss wants crackdown on individual hooligans
This content was published on
The head of the Swiss Football League says he prefers a harsher approach to individual hooligans rather than collective punishment measures affecting all fans.
Amherd: Council of Europe is ‘as urgently needed as ever’
This content was published on
The Swiss government emphasised on Sunday the vital role of the Strasbourg-based Council of Europe, 75 years after it was founded.
Swiss minister: Italy will back Switzerland in EU talks
This content was published on
Bern can count on the backing of Italy as it re-enters talks with the European Union on future relations, Viola Amherd says.
Student protestors at University of Lausanne continue pro-Palestine sit-in
This content was published on
Since Thursday, a hall on campus has been occupied by students calling for a boycott of Israeli academic institutions and a ceasefire in Gaza.
This content was published on
Swiss public broadcasters RTS and SRF are drastically reducing their communications via the social network X (formerly Twitter).
Israel: president of Swiss universities rejects academic boycott
This content was published on
Luciana Vaccaro, president of Swissuniversities, the umbrella group of Swiss universities, is not in favour of an academic boycott of Israeli universities.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss non-profit aims to break taboo of women’s brain health
This content was published on
If depression is twice as common in women than men worldwide, does that mean we need to change how we think about gender, health, and science?
This content was published on
The director of the Brain Mind Institute at the Federal Institute of Technology in Lausanne is leading a major new national research project, “Synapsy”, into the neurobiological mechanisms behind mental and cognitive disorders. The research, funded by the Swiss National Science Foundation and launched at the beginning of October, aims to bring the two disciplines…
This content was published on
There are far more people with dementia in Switzerland than previously thought – and the number is expected to double over the next 25 years.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.